Pancreatic Cancer

    A Randomized Phase II Study of Gemcitabine and Nab- Paclitaxel Compared with 5-Fluorouracil, Leucovorin, and Liposomal Irinotecan in Older Patients with Treatment Naive Metastatic Pancreatic Cancer (GIANT)

    PI: Grant Williams, M.D.

  • ETCTN-10208
    A Phase I study of Anetumab Ravtansine in Combination with either Anti-PD-1 Antibody, or Anti-CTLA4 and Anti-PD-1 Antibodies or Anti-PD-1 Antibody and Gemcitabine in Mesothelin-Positive Advanced Pancreatic Adenocarcinoma

    PI: Olumide Gbolahan, M.D.
  • UAB1926
    Disposable Perfusion Phantom for Accurate DCE-MRI Measurement of Pancreatic Cancer Therapy Response

    PI: Harrison Kim, Ph.D.
  • ALLIANCE A021806
    Randomized Phase III study comparing up front surgery to perioperative FOLFIRINOX of resectable pancreatic cancer

    PI: J Bart Rose, M.D.
  • UAB1707
    Phase I SG CD40

    PI: Olumide Gbolahan, M.D.
  • UAB2039
    Irinotecan liposome injection, oxaliplatin, 5FU / leucovorin vs. nab-paclitaxel + Gem in previously untreated metastatic adenocarcinoma of the pancreas

    PI: Grant Williams, M.D.
  • UAB1830
    Phase I Minnelide Capsules Stage IV

    PI: Olumide Gbolahan, M.D.